Your browser doesn't support javascript.
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview.
Deumer, Undine-Sophie; Varesi, Angelica; Floris, Valentina; Savioli, Gabriele; Mantovani, Elisa; López-Carrasco, Paulina; Rosati, Gian Marco; Prasad, Sakshi; Ricevuti, Giovanni.
  • Deumer US; Department of Biological Sciences, Faculty of Natural Sciences and Mathematics, University of Cologne, 50674 Cologne, Germany.
  • Varesi A; Department of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy.
  • Floris V; Almo Collegio Borromeo, 27100 Pavia, Italy.
  • Savioli G; Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
  • Mantovani E; Emergency Department, IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • López-Carrasco P; Department of Neurosciences, Biomedicine and Movement Sciences, Neurology Section, University of Verona, 37129 Verona, Italy.
  • Rosati GM; División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
  • Prasad S; Medicine and Surgery, Humanitas University, 20090 Milano, Italy.
  • Ricevuti G; National Pirogov Memorial Medical University, 21018 Vinnytsya, Ukraine.
J Clin Med ; 10(20)2021 Oct 19.
Article in English | MEDLINE | ID: covidwho-1477963
ABSTRACT
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic systemic disease that manifests via various symptoms such as chronic fatigue, post-exertional malaise, and cognitive impairment described as "brain fog". These symptoms often prevent patients from keeping up their pre-disease onset lifestyle, as extended periods of physical or mental activity become almost impossible. However, the disease presents heterogeneously with varying severity across patients. Therefore, consensus criteria have been designed to provide a diagnosis based on symptoms. To date, no biomarker-based tests or diagnoses are available, since the molecular changes observed also largely differ from patient to patient. In this review, we discuss the infectious, genetic, and hormonal components that may be involved in CFS pathogenesis, we scrutinize the role of gut microbiota in disease progression, we highlight the potential of non-coding RNA (ncRNA) for the development of diagnostic tools and briefly mention the possibility of SARS-CoV-2 infection causing CFS.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Jcm10204786

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Prognostic study Language: English Year: 2021 Document Type: Article Affiliation country: Jcm10204786